These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 26048771)
21. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Kimura Y; Miyazaki N; Hayashi N; Otsuru S; Tamai K; Kaneda Y; Tabata Y Tissue Eng Part A; 2010 Apr; 16(4):1263-70. PubMed ID: 19886805 [TBL] [Abstract][Full Text] [Related]
22. Injectable Hyaluronan Hydrogels with Peptide-Binding Dendrimers Modulate the Controlled Release of BMP-2 and TGF-β1. Seelbach RJ; Fransen P; Pulido D; D'Este M; Duttenhoefer F; Sauerbier S; Freiman TM; Niemeyer P; Albericio F; Alini M; Royo M; Mata A; Eglin D Macromol Biosci; 2015 Aug; 15(8):1035-44. PubMed ID: 25943094 [TBL] [Abstract][Full Text] [Related]
23. Injectable colloidal hydrogel with mesoporous silica nanoparticles for sustained co-release of microRNA-222 and aspirin to achieve innervated bone regeneration in rat mandibular defects. Lei L; Liu Z; Yuan P; Jin R; Wang X; Jiang T; Chen X J Mater Chem B; 2019 Apr; 7(16):2722-2735. PubMed ID: 32255005 [TBL] [Abstract][Full Text] [Related]
24. Stimulation of bone regeneration following the controlled release of water-insoluble oxysterol from biodegradable hydrogel. Hokugo A; Saito T; Li A; Sato K; Tabata Y; Jarrahy R Biomaterials; 2014 Jul; 35(21):5565-71. PubMed ID: 24731715 [TBL] [Abstract][Full Text] [Related]
25. Theranostic Bioabsorbable Bone Fixation Plate with Drug-Layered Double Hydroxide Nanohybrids. Kim MH; Hur W; Choi G; Min HS; Choi TH; Choy YB; Choy JH Adv Healthc Mater; 2016 Nov; 5(21):2765-2775. PubMed ID: 27723270 [TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate-linked hyaluronic acid hydrogel sequesters and enzymatically releases active bone morphogenetic protein-2 for induction of osteogenic differentiation. Hulsart-Billström G; Yuen PK; Marsell R; Hilborn J; Larsson S; Ossipov D Biomacromolecules; 2013 Sep; 14(9):3055-63. PubMed ID: 23947433 [TBL] [Abstract][Full Text] [Related]
27. Controlled drug release for tissue engineering. Rambhia KJ; Ma PX J Control Release; 2015 Dec; 219():119-128. PubMed ID: 26325405 [TBL] [Abstract][Full Text] [Related]
28. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering. Ji Y; Xu GP; Zhang ZP; Xia JJ; Yan JL; Pan SH Ann Biomed Eng; 2010 Mar; 38(3):632-9. PubMed ID: 20049636 [TBL] [Abstract][Full Text] [Related]
29. Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2. Yang HS; La WG; Bhang SH; Jeon JY; Lee JH; Kim BS Tissue Eng Part A; 2010 Apr; 16(4):1225-33. PubMed ID: 19886733 [TBL] [Abstract][Full Text] [Related]
30. A biomimetic growth factor delivery strategy for enhanced regeneration of iliac crest defects. Huri PY; Huri G; Yasar U; Ucar Y; Dikmen N; Hasirci N; Hasirci V Biomed Mater; 2013 Aug; 8(4):045009. PubMed ID: 23782488 [TBL] [Abstract][Full Text] [Related]
31. Regeneration of calvarial defects with Escherichia coli -derived rhBMP-2 adsorbed in PLGA membrane. Ono M; Sonoyama W; Nema K; Hara ES; Oida Y; Pham HT; Yamamoto K; Hirota K; Sugama K; Sebald W; Kuboki T Cells Tissues Organs; 2013; 198(5):367-76. PubMed ID: 24434422 [TBL] [Abstract][Full Text] [Related]
32. Analysis of hydrolyzable polyethylene glycol hydrogels and deproteinized bone mineral as delivery systems for glycosylated and non-glycosylated bone morphogenetic protein-2. Hänseler P; Jung UW; Jung RE; Choi KH; Cho KS; Hämmerle CH; Weber FE Acta Biomater; 2012 Jan; 8(1):116-23. PubMed ID: 21867781 [TBL] [Abstract][Full Text] [Related]
33. Segmental bone regeneration using rhBMP-2-loaded collagen/chitosan microspheres composite scaffold in a rabbit model. Hou J; Wang J; Cao L; Qian X; Xing W; Lu J; Liu C Biomed Mater; 2012 Jun; 7(3):035002. PubMed ID: 22358865 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterization of grafted thermosensitive hydrogels for heating activated controlled release. Ankareddi I; Brazel CS Int J Pharm; 2007 May; 336(2):241-7. PubMed ID: 17234371 [TBL] [Abstract][Full Text] [Related]
35. A micelle-shedding thermosensitive hydrogel as sustained release formulation. de Graaf AJ; Azevedo Próspero dos Santos II; Pieters EH; Rijkers DT; van Nostrum CF; Vermonden T; Kok RJ; Hennink WE; Mastrobattista E J Control Release; 2012 Sep; 162(3):582-90. PubMed ID: 22971272 [TBL] [Abstract][Full Text] [Related]
36. Bone regeneration using cell-mediated responsive degradable PEG-based scaffolds incorporating with rhBMP-2. Yang F; Wang J; Hou J; Guo H; Liu C Biomaterials; 2013 Feb; 34(5):1514-28. PubMed ID: 23187021 [TBL] [Abstract][Full Text] [Related]
37. Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Serra L; Doménech J; Peppas NA Eur J Pharm Biopharm; 2009 Mar; 71(3):519-28. PubMed ID: 18976706 [TBL] [Abstract][Full Text] [Related]
38. Matrices for combined delivery of proteins and synthetic molecules. Gilmore KA; Lampley MW; Boyer C; Harth E Adv Drug Deliv Rev; 2016 Mar; 98():77-85. PubMed ID: 26656604 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization and controlled drug release of thermosensitive IPN-PNIPAAm hydrogels. Zhang XZ; Wu DQ; Chu CC Biomaterials; 2004 Aug; 25(17):3793-805. PubMed ID: 15020155 [TBL] [Abstract][Full Text] [Related]
40. Sequential delivery of BMP-2 and BMP-7 for bone regeneration using a heparinized collagen membrane. Jo JY; Jeong SI; Shin YM; Kang SS; Kim SE; Jeong CM; Huh JB Int J Oral Maxillofac Surg; 2015 Jul; 44(7):921-8. PubMed ID: 25769221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]